These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12653538)

  • 21. Network and pathway analysis of compound-protein interactions.
    Brennan RJ; Nikolskya T; Bureeva S
    Methods Mol Biol; 2009; 575():225-47. PubMed ID: 19727618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of molecular fingerprint methods on the basis of biological profile data.
    Steffen A; Kogej T; Tyrchan C; Engkvist O
    J Chem Inf Model; 2009 Feb; 49(2):338-47. PubMed ID: 19434835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From structure-activity to structure-selectivity relationships: quantitative assessment, selectivity cliffs, and key compounds.
    Peltason L; Hu Y; Bajorath J
    ChemMedChem; 2009 Nov; 4(11):1864-73. PubMed ID: 19750525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analogs of methyllycaconitine as novel noncompetitive inhibitors of nicotinic receptors: pharmacological characterization, computational modeling, and pharmacophore development.
    McKay DB; Chang C; González-Cestari TF; McKay SB; El-Hajj RA; Bryant DL; Zhu MX; Swaan PW; Arason KM; Pulipaka AB; Orac CM; Bergmeier SC
    Mol Pharmacol; 2007 May; 71(5):1288-97. PubMed ID: 17308033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bayesian interpretation of a distance function for navigating high-dimensional descriptor spaces.
    Vogt M; Godden JW; Bajorath J
    J Chem Inf Model; 2007; 47(1):39-46. PubMed ID: 17238247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian screening for active compounds in high-dimensional chemical spaces combining property descriptors and molecular fingerprints.
    Vogt M; Bajorath J
    Chem Biol Drug Des; 2008 Jan; 71(1):8-14. PubMed ID: 18069988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a lead pharmacophore for the development of potent nuclear receptor modulators as anticancer and X syndrome disease therapeutic agents.
    Lin HR; Abraham DJ
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4178-83. PubMed ID: 16784849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of molecules based on shape and electrostatic similarity: proof of concept of "electroforms".
    Jennings A; Tennant M
    J Chem Inf Model; 2007; 47(5):1829-38. PubMed ID: 17824684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From activity cliffs to activity ridges: informative data structures for SAR analysis.
    Vogt M; Huang Y; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular similarity: a key technique in molecular informatics.
    Bender A; Glen RC
    Org Biomol Chem; 2004 Nov; 2(22):3204-18. PubMed ID: 15534697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicogenomics screening of small molecules using high-density, nanocapillary real-time PCR.
    Vass L; Kelemen JZ; Fehér LZ; Lorincz Z; Kulin S; Cseh S; Dormán G; Puskás LG
    Int J Mol Med; 2009 Jan; 23(1):65-74. PubMed ID: 19082508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Data mining a small molecule drug screening representative subset from NIH PubChem.
    Xie XQ; Chen JZ
    J Chem Inf Model; 2008 Mar; 48(3):465-75. PubMed ID: 18302356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Data fusion of similarity and dissimilarity measurements using Wiener-based indices for the prediction of the NPY Y5 receptor antagonist capacity of benzoxazinones.
    Ruiz IL; Urbano-Cuadrado M; Gómez-Nieto MA
    J Chem Inf Model; 2007; 47(6):2235-41. PubMed ID: 17902643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.
    Nettles JH; Jenkins JL; Bender A; Deng Z; Davies JW; Glick M
    J Med Chem; 2006 Nov; 49(23):6802-10. PubMed ID: 17154510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicinal chemistry tools: making sense of HTS data.
    Kolossov E; Lemon A
    Eur J Med Chem; 2006 Feb; 41(2):166-75. PubMed ID: 16368163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basic overview of chemoinformatics.
    Engel T
    J Chem Inf Model; 2006; 46(6):2267-77. PubMed ID: 17125169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.